HIF-1α/VEGF axis, as a key regulator of tumor growth and metastasis, could be a promising drug target for RES in the development of an effective anticancer therapy for the prevention of hepatic tumor growth and metastasis. The gene discussed is HIF1A; the disease is neoplasm.